Health-related Quality of Life and survivorship in Locally Recurrent Rectal Cancer. The LRRC-QoL study

niversity of Leeds0 个研究点目标入组 320 人开始时间: 2021年12月20日最近更新: 2023年1月9日

适应症

试验速览

暂无简介。

•Workstream I:
•1.1 Aged over or equal to 18 years
•1.2 Radiological and/or histological diagnosis of locally recurrent rectal cancer
•1.3 Undergone treatment for locally recurrent rectal cancer within the last 2 years
•1.4 Able to provide informed written consent to participate
•1.5 Able to read and write in the target language.
•Workstream II:
•2.1 Aged over or equal to 18 years
•2.2 New radiological and/or histological diagnosis of locally recurrent rectal cancer
•2.3 Able to provide informed written consent to participate
•2.4 Able to read and write in the target language.
•Workstream III:
•3.1 Aged over or equal to 18 years
•3.2 Treated for locally recurrent rectal cancer and are disease-free for more than 3 years
•3.3 Able to provide informed written consent to participate
•3.4 Able to read and write in the target language

•1. Patients with cognitive impairment
•2. Patients who are in remission from treatment of primary rectal cancer with no evidence of local recurrence
•3. Patients who are receiving treatment for distant metastatic disease following previous treatment of rectal cancer with no evidence of local recurrence

发起方

niversity of Leeds